SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)

ETR:1SXP Revenue

SCHOTT Pharma AG & Co. KGaA had revenue of 281.76M EUR in the quarter ending June 30, 2026, with 9.99% growth. This brings the company's total for the last twelve months to 1.02B, up 4.15% year-over-year. In the fiscal year ending September 30, 2025, SCHOTT Pharma AG & Co. KGaA had annual revenue of 986.21M with 3.04% growth. That makes SCHOTT Pharma AG & Co. KGaA the 7,032nd largest company in the world by revenue and 160th in Germany.

• Revenue (ttm): 1.02B
• Revenue Growth: +4.15%
• P/S Ratio: 3.82
• Revenue / Employee: 203.28K
• Employees: 5,002
• Market Cap: 3.85B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Drug Containment Solutions (DCS) 548.01M 55.5%
• Drug Delivery Systems (DDS) 438.76M 44.5%

By Geography

Chart

• EMEA 638.71M 64.8%
• North America 151.74M 15.4%
• Asia and South Pacific 109.90M 11.1%
• South America 85.86M 8.7%

Fiscal year ended Sep 30, 2025 See the full ETR:1SXP breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2025	986.21M	29.12M	3.04%
Sep 30, 2024	957.09M	58.49M	6.51%
Sep 30, 2023	898.60M	77.46M	9.43%
Sep 30, 2022	821.14M	172.48M	26.59%
Sep 30, 2021	648.67M	64.44M	11.03%

Data Source: S&P Global Market Intelligence Last updated: Aug 12, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 18, 2026

Data Sources Report a data error